Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. (PACB) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · PACB · as of Jun 8, 2026
Key Statistics
Explore Pacific Biosciences of California, Inc. Data
pacb stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 18 · Buy rate: 50.0%
The PACB analyst consensus is Buy, based on ratings from 18 Wall Street analysts over the past 3 months. The average 12-month price target is $1.00, representing -26.74% downside from the current price of $1.36.
Competitors & Peers
pacb competitorsPACB
AVNS
BFLY
DNA
DRIO
FLGTStock Performance
Full HistoryAbout Pacific Biosciences of California, Inc.
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, a…
what is pacific biosciences of california, inc. · pacb stock overview · pacific biosciences of california, inc. company profile · who is pacific biosciences of california, inc. ceo · pacb NASDAQ · pacific biosciences of california, inc. headquarters · pacific biosciences of california, inc. business segments
About Stock Overview & Key Data
Pacific Biosciences of California, Inc. (PACB) is a Healthcare company in the Medical - Devices industry, listed on NASDAQ since Oct 27, 2010. As of the latest trading session, PACB stock price is $1.36, with a market capitalization of $424.0M. The stock has returned +13.33% over the past 12 months and -27.27% year-to-date.
According to 18 Wall Street analysts, the consensus rating for Pacific Biosciences of California, Inc. stock is Buy, with an average 12-month price target of $1.00. In fiscal year 2025, Pacific Biosciences of California, Inc. reported revenue of $160.0M and net income of -$546.4M. For detailed data — including Pacific Biosciences of California, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Pacific Biosciences of California, Inc. (PACB) stock price is $1.36. The stock is traded on NASDAQ under the ticker symbol PACB. The 52-week range is $0.99 – $2.73.